Spectrum Vascular announced today that it added to its executive team with the appointment of Ken Miller as CEO and Doug Shook as CCO.
The company said its leadership appointments help advance its mission to deliver improved patient outcomes and scale impact. They build upon recent momentum, according to a news release, following a strategic investment by SK Capital last month.
White Plains, New York–based Spectrum Vascular provides vascular access products to deliver antimicrobial protection and thrombus reduction. It was formed through the acquisition of the vascular access businesses of Cook Medical and AngioDynamics in 2023 and 2024, respectively.
“Ken and Doug are proven leaders who share our values and vision,” said Jon Borell, Managing Director at SK Capital. “The Spectrum Vascular board of directors, as well as the SK Capital and Event Capital Strategies teams, are thrilled to partner with them as we position Spectrum for its next chapter.”
More about the new executive appointments at Spectrum Vascular
Miller has more than 35 years of leadership experience in the medical device industry. He joins from Koru Medical Systems, an infusion technology company, where he served as CCO starting in 2023.
Before Koru, Miller held executive leadership positions at Nasco Healthcare, BD, and Novo Nordisk.
“I am honored to join Spectrum Vascular at such a critical stage in its journey,” said Mr. Miller. “The company’s commitment to patient care and innovation, combined with the recent support from SK Capital, create a strong foundation for growth. I look forward to working with the Spectrum team to elevate our impact and expand access to Spectrum’s critical care technologies.”
Shook has more than two decades of commercial leadership experience in medtech, the company said. He joins from ICU Medical, where he served as global business unit leader for vascular access. He led ICU Medical’s commercial operations across the vascular access portfolios.
Prior to ICU Medical, Shook held commercial leadership posts at Smiths Medical (acquired by ICU) and Access Scientific.
“I’m excited to join Spectrum at a time of strong momentum and opportunity,” said Shook. “With a differentiated portfolio and clear focus on infection prevention, we’re well-positioned to expand our market presence and deepen our impact across healthcare systems.”
